SCHEMBL8685078

SCHEMBL8685078

O=C1NC(=O)C(=Cc2cccc3[nH]ccc23)S1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.63
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ AKR1B1 P15121 1/20 0.63
▸ IGF1R P08069 3/20 0.55
▸ NAT1 P18440 1/20 0.55
▸ CISD1 Q9NZ45 2/20 0.51
▸ GSK3B P49841 1/20 0.51
▸ PIM1 P11309 6/20 0.50
▸ PIM2 Q9P1W9 5/20 0.50
▸ PIM3 Q86V86 3/20 0.50
▸ TDP2 O95551 1/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ CASP9 P55211 1/20 0.50
▸ CASP6 P55212 1/20 0.50
▸ CASP8 Q14790 1/20 0.50
▸ HPGD P15428 1/20 0.47
▸ GSK3A P49840 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8686801 1.00 TTR (0.63) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL1249878 0.81 MEN1 (0.61) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL2422392 0.81 MEN1 (0.61) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL1249881 0.81 MEN1 (0.61) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL30343486 0.81 MEN1 (0.61) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL1248821 0.78 KMT2A (1.00) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL1248823 0.78 KMT2A (1.00) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL2428494 0.76 TTR (0.60) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL2428488 0.76 TTR (0.60) TTRMEN1KMT2AAKR1B1IGF1R
SCHEMBL2428491 0.76 TTR (0.60) TTRMEN1KMT2AAKR1B1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 — — US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 — — EP disclosed
Send feedback